Latest Breaking News On - மைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் - Page 2 : vimarsana.com

Ramdev deserves to be prosecuted for trashing modern medicine: IMA

Ramdev deserves to be prosecuted for trashing modern medicine: IMA By IANS | 0 Views Ramdev deserves to be prosecuted for trashing modern medicine: IMA ( . Image Source: IANS News New Delhi, May 22 : In a stinging attack on Ramdev, the Indian Medical Association (IMA) has alleged that the yoga guru is creating a false sense of fear and frustration in the public at large so that he can sell his illegal and unapproved so-called medicines and make money at the cost of the people. IMA brings to the notice of our Health Minister, a video circulating in social media portraying the celebrated Yoga guruji addressing ALLOPATHY EK AISI STUPID AUR DIWALIYA SCIENCE HAI . In the past too, he had uttered modern medical doctors as murderers in the presence of the Health Minister himself on the pretext of the release of his wonder drugs, the IMA said in a statement.

New delhiBalkrishna jiTamanna hashmiCentral drug standard control organisationIndian medical associationHealth ministerEpidemic decease actபுதியது டெல்ஹிதமன்னா ஹாஷ்மிமைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்இந்தியன் மருத்துவ சங்கம்ஆரோக்கியம் அமைச்சர்

Prosecute Ramdev for remarks against allopathy or dissolve modern medical facilities: IMA to Centre

The yoga guru claimed that allopathy was a ‘stupid science’ and that lakhs of Covid patients had died because of these medicines.

Harsh vardhanShri balkrishnaPatanjali ayurvedUnion healthCentral drug standard control organisationWorld health organizationIndian medical associationBharatiya janata partyIndian medical association onDrugs controller generalEpidemic diseases actUnion health minister harshEpidemic disease actYogi guruHealth minister harsh vardhanNews nation

Torrent Pharmaceuticals enters into licensing agreement with Eli Lilly

To manufacture and distribute baricitinib in IndiaTorrent Pharmaceuticals announced that it has entered into a royalty free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, joining a group of leading Indian pharmaceutical companies for baricitinib for Covid-19 in India. Under the agreement, Lilly has provided the license to manufacture and distribute baricitinib to Torrent for India along with Lilly s other license partners. The agreement will help ensure wider reach and access to patients in India and further adds to Torrent Pharma s effort in helping patients af fected by the pandemic. Baricitinib has been approved by the Central Drug Standard Control Organisation (CDSCO), India for restricted emergency use in combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.

Eli lillyCentral drug standard control organisationIndiatorrent pharmaceuticalsTorrent pharmaCapital marketஎலி லில்லிமைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்நீரோடை பார்மாமூலதனம் சந்தை

Torrent Pharma inks pact with Eli Lilly for Covid drug Baricitinib in India

Torrent Pharma enters into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India

Torrent Pharma enters into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Eli lillyRaman mehtaCentral drug standard control organisationTorrent pharmaceuticals limitedTorrent groupVoluntary licensing agreementTime zonePharmaceuticals limitedTorrent pharmaChief marketing officerஎலி லில்லிஒரு மனிதன் மேத்தாமைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்நீரோடை மருந்துகள் வரையறுக்கப்பட்டவைநீரோடை குழுநேரம் ஸோந்